Literature DB >> 6795716

Intestinal salivary, and tonsillar IgA and J-chain production in a patient with severe deficiency of serum IgA.

P Brandtzaeg, D Guy-Grand, C Griscelli.   

Abstract

An 18-year-old man with tendency to respiratory infections had a serum IgA level of only 2% of normal whereas his salivary IgA amounted to 50% of the lower normal concentration range. Moreover, both the rectal and jejunal IgA-producing cell populations were of normal size. Nevertheless, a relative increase of salivary IgM and a distinctly raised number of IgM-producing cells in jejunal mucosa indicated an imbalance in his secretory immune system. This possibility was supported by the presence of an excess of J 3 chains in most of his intestinal IgA immunocytes, probably reflecting a reduced synthetic rate of IgA. The number of tonsillar IgA-producing cells was only slightly below the normal range; most of them lacked J chain, as normal, and could thus be a source of his serum IgA, which was mainly monomeric. A marked deficiency of IgA-producing cells in his bone marrow supported the notion that this tissue site normally is the major source of monomeric IgA. This study suggests that a generally defective IgA system may be topically activated owing to the persistent antigenic and mitogenic load on mucosa-associated lymphoid tissues. Our findings are not consistent with a general regulative compartmentalization of monomer- and dimer-producing IgA immunocyte populations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795716     DOI: 10.1111/j.1365-3083.1981.tb00140.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Terminally differentiated human intestinal B cells. J chain expression of IgA and IgG subclass-producing immunocytes in the distal ileum compared with mesenteric and peripheral lymph nodes.

Authors:  K Bjerke; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Immunoglobulin-producing cells in secretory immune system in patients with selective IgA deficiency.

Authors:  T Kanoh; O Nishida; H Uchino; T Miyake
Journal:  Gastroenterol Jpn       Date:  1987-08

3.  The IgA immune system in epileptics on anticonvulsant therapy.

Authors:  O Meissner; P H Joubert; H F Joubert; C A van der Merwe
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency.

Authors:  D E Nilssen; P Aukrust; S S Frøland; F Müller; O Fausa; T S Halstensen; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

5.  Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency.

Authors:  D E Nilssen; P Brandtzaeg; S S Frøland; O Fausa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.